Figure 1.

Panel (A): leukocyte telomere length (LTL) (mean ± SE) of male and female subjects with “good compliance” (n = 407), at initial assessment (white bars) and at 12 months (shaded bars). Panel (B): leukocyte telomere length (LTL) of male and female, prepubertal, and pubertal at initial assessment subjects with “good compliance” (n = 407), at initial assessment (white bars) and at 12 months (shaded bars). All measured variables were compared by employing repeated-measures ANOVA. Significant main effects were revealed by LSD post-hoc test. Statistical significance was set at (p < 0.05). * Indicates significant difference between initial assessment and the 12 months follow-up, time-points; ‡ Indicates significant difference from the Male group.